Do mast cell mediators like tryptase and histamine cause reflux-like symptoms by increasing esophageal sensitivity?

Reflux-like symptoms often persist despite optimal acid suppression therapy, suggesting that non-acidic factors—specifically neuroimmune interactions—play a significant role in esophageal sensitivity. Research indicates that mast cell activation is a critical driver of these symptoms through the modulation of local nerve endings.

Mechanistic pathways of hypersensitivity

The release of mediators during mast cell degranulation, particularly tryptase and histamine, initiates a cascade that lowers the threshold for pain signaling in the viscera:

• Tryptase and PAR2: Tryptase, a serine protease, cleaves and activates protease-activated receptor 2 (PAR2) on sensory neurons. This activation triggers downstream signaling that sensitizes transient receptor potential vanilloid 1 (TRPV1) ion channels.
• Histamine and H1 Receptors: Histamine acts via H1 receptors to further sensitize these same TRPV1 channels on visceral afferent fibers.
• Sensitization: The convergence of these pathways on TRPV1 channels enhances the neuronal response to mechanical distension and chemical stimuli, leading to a state of hypersensitivity where normal esophageal activity is perceived as painful.

Clinical evidence in reflux symptoms

Evidence increasingly links mast cell density and activity to symptomatic presentations that mimic gastroesophageal reflux disease (GERD), even in the absence of mucosal erosion:

• Increased Mast Cell Density: Patients with non-erosive reflux disease (NERD) exhibit significantly higher mast cell density in the esophageal mucosa (approximately 7.23 cells/HPF) compared to healthy controls (3.79 cells/HPF).
• Symptom Correlation: High mast cell counts and mediator levels correlate with increased symptom severity, such as heartburn and chest pain, particularly in functional esophageal disorders where standard acid exposure metrics (pH monitoring) are often normal.
• Neuroimmune Axis: These findings suggest a neuroimmune axis where mast cell mediators activate sensitized nociceptors, explaining why some patients remain symptomatic despite successful acid suppression.

Bottom line

• Mast cells release tryptase and histamine that sensitize esophageal nerve endings via PAR2 and TRPV1 pathways, directly contributing to visceral hypersensitivity and reflux-like symptoms independent of acid exposure.